The companies said their vaccine helped prevent the return and spread of melanoma in a trial that involved more than 1,000 ...
9h
'Cancer vaccines are coming': Merck, Moderna clear Phase 3 hurdle as Korean biotech joins the race
The messenger RNA (mRNA) technology that became humanity's frontline defense during the COVID-19 pandemic has now crossed a ...
WATE 6 On Your Side on MSN
Moderna, Merck mRNA cancer vaccine prevents melanoma from returning in trial
The study also met a secondary goal of preventing cancer from spreading to different parts of the body.
Tempus AI, Inc. made a timely move to acquire the Personalis cancer monitoring tests to advance AI-driven precision medicine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results